Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Negrin

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cellsIrina Fernandez, Robert Zeiser, Holger Karsunky, et al.
Plos One|January 30, 2014
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationEmanuela I Sega, Dennis B Leveson-Gower, Mareike Florek, et al.
Blood|October 24, 2002
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imagingMatthias Edinger, Yu-An Cao, Michael R Verneris, et al.
Blood|January 4, 2003
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantationHeather G Shilling, Karina L McQueen, Nathalie W Cheng, et al.
Blood|March 22, 2015
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethalityDominik Schneidawind, Jeanette Baker, Antonio Pierini, et al.
Blood|July 8, 2011
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cellsHo-Jin Shin, Jeanette Baker, Dennis B Leveson-Gower, et al.
Cytotherapy|March 16, 2020
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cellsMatthew J Frank, Niclas Olsson, Andy Huang, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cellsMobin Karimi, Thai M Cao, Jeanette A Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cellsIrina Fernandez, Robert Zeiser, Holger Karsunky, et al.
Plos One|January 30, 2014
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantationEmanuela I Sega, Dennis B Leveson-Gower, Mareike Florek, et al.
Blood|October 24, 2002
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imagingMatthias Edinger, Yu-An Cao, Michael R Verneris, et al.
Blood|January 4, 2003
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantationHeather G Shilling, Karina L McQueen, Nathalie W Cheng, et al.
Blood|March 22, 2015
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethalityDominik Schneidawind, Jeanette Baker, Antonio Pierini, et al.
Blood|July 8, 2011
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cellsHo-Jin Shin, Jeanette Baker, Dennis B Leveson-Gower, et al.
Cytotherapy|March 16, 2020
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cellsMatthew J Frank, Niclas Olsson, Andy Huang, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Pageof 17